Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation

BACKGROUND: Polypharmacy is highly prevalent in elderly people with chronic conditions, including atrial fibrillation (AF). The impact of polypharmacy on adverse outcomes and on treatment effectiveness in elderly patients with AF remains unaddressed. METHODS AND RESULTS: We studied 338 810 AF patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Nemin, Alam, Aniqa B., Lutsey, Pamela L., MacLehose, Richard F., Claxton, J'Neka S., Chen, Lin Y., Chamberlain, Alanna M., Alonso, Alvaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429010/
https://www.ncbi.nlm.nih.gov/pubmed/32448024
http://dx.doi.org/10.1161/JAHA.119.015089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429010/
https://www.ncbi.nlm.nih.gov/pubmed/32448024
http://dx.doi.org/10.1161/JAHA.119.015089

Ejemplares similares